Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2003Science

Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPaul M. SteedMTMalú G. TanseyJZJonathan Zalevsky

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Steed et al. (2003) studied this question.

synapsesocial.com/papers/6a7f23f2b4cedf233c7c9be9https://doi.org/10.1126/science.1081297
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis2000 · 165 citations
  2. 2Caspases: the executioners of apoptosis1997 · 4,757 citations
  3. 3TNF-R1 Signaling: A Beautiful Pathway2002 · 1,935 citations
  4. 4PEGylated Recombinant Human Tumor Necrosis Factor Alpha: Pharmacokinetics and Anti-tumor Effects.2001 · 8 citations
  5. 5High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris1989 · 154 citations